Navigation Links
Insmed To Present At Two Upcoming Investor Conferences
Date:11/12/2012

MONMOUTH JUNCTION, N.J., Nov. 12, 2012 /PRNewswire/ -- Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical company focused on developing inhaled therapeutics for serious diseases of the lung, today announced that Will Lewis, President and Chief Executive Officer, will be presenting a corporate overview at the Lazard Capital Markets 9th Annual Healthcare Conference and the Oppenheimer 23rd Annual Healthcare Conference.

Mr. Lewis will present at the Lazard Capital Markets 9th Annual Healthcare Conference in New York on Tuesday, November 13, 2012, at 10:30 AM ET, and at the Oppenheimer 23rd Annual Healthcare Conference, also in New York, on Wednesday, December 12, 2012 at 10:00 AM ET.

Live audio webcasts will be made available for both presentations on Insmed's website, http://www.insmed.com.  The webcasts will both be archived for 90 days.

About Insmed

Insmed Incorporated is a biopharmaceutical company dedicated to improving the lives of patients battling serious orphan lung diseases through the development and commercialization of novel, targeted inhalation therapies in orphan patient populations with critical unmet needs.  Insmed's lead candidate, ARIKACE®, is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the efficacy, safety and convenience of treatment for at least two identified patient populations: cystic fibrosis (CF) patients with Pseudomonas lung infections and patients with nontuberculous mycobacteria lung infections (NTM). Following positive phase 2 results in CF patients, Insmed's phase 3 registrational study of ARIKACE (CLEAR-108) in Europe and Canada is well underway, as is the U.S. Phase 2 trial in NTM (TARGET-NTM). The Company expects to report clinical results from both the CF Phase 3 and NTM Phase
'/>"/>

SOURCE Insmed Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Insmed to Host 2012 First Quarter Earnings Conference Call
2. Insmed Incorporated Announces Lifting of Clinical Hold by U.S. Food and Drug Administration on ARIKACE® in Cystic Fibrosis Patients With Pseudomonas Lung Infections
3. Insmed Announces First Quarter 2012 Financial Results
4. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
5. Insmed To Present At JMP Securities 7th Annual Healthcare Conference
6. Insmed to Host 2012 Second Quarter Earnings Conference Call
7. Insmed Announces Planned Departure Of Chief Financial Officer
8. Pharmaceutical Industry Veteran Al Altomari Elected To Insmeds Board Of Directors
9. Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference
10. Insmed Appoints Will Lewis as President and Chief Executive Officer
11. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Chindex International, Inc. ("Chindex" or the "Company") ... special meeting of stockholders held today, the Company,s stockholders ... by and among the Company, Healthy Harmony Holdings, L.P. ... is an affiliate of TPG, Shanghai Fosun Pharmaceutical (Group) ... the CEO of the Company. The Merger ...
(Date:9/16/2014)... 2014 Research and Markets has announced ... report to their offering. Animal vaccines ... Animal vaccines are generally prepared from weakened or dead microbes ... state. Some of the animal vaccines are also formulated using ... or toxic components. These components act as ...
(Date:9/16/2014)... 2014 QPID Health , a leader in ... in Boston and their first West ... at 175 Franklin Street in Boston , ... Health,s new Southern California office will ... will help meet the demands of customers nationwide.  Both new ...
Breaking Medicine Technology:Chindex Stockholders Approve Merger 2Chindex Stockholders Approve Merger 3Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 2Global Animal Vaccines Market 2014-2018: Key Vendors are Bayer, Elanco, Merck, Novartis, Sanofi and Zoetis 3QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2
... New data being presented at the American ... in San Diego showed that treatment with KAPIDEX(TM) ... resulted in a statistically significant greater percentage of ... reflux disease (GERD), compared to placebo (p<0.001). In ...
... for Medco Health Solutions, Inc. (NYSE: MHS ) ... , Timothy Wentworth, Medco,s group president for employer accounts, ... Wednesday, November 4, 2009 at 2:10 p.m. ET at ... Snow Jr., Medco chairman and CEO, will address the ...
Cached Medicine Technology:New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD 2New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD 3Medco to Present at November 2009 Investor Conferences 2
(Date:9/16/2014)... (PRWEB) September 16, 2014 Advanced Fertility ... recently named by Houstonia Magazine as one of the ... by Houstonia Magazine - a metropolitan magazine serving the ... area and recognize them for their outstanding services. This ... 2014 edition of Houstonia Magazine — a special publication ...
(Date:9/16/2014)... great promise in helping people to reach their ... help the wearers improve their wellness by constantly ... is organized into companion computer programs and mobile ... growing market for these devices, researchers at the ... 13 of these activity monitors, such as those ...
(Date:9/16/2014)... A new study found that fractional flow ... true coronary bifurcation lesions yields similar outcomes to ... trial is the first study to compare FFR-guided ... today at the 26th annual Transcatheter Cardiovascular Therapeutics ... Foundation (CRF), TCT is the world,s premier educational ...
(Date:9/16/2014)... Ind. - Ensuring that corn absorbs the right balance ... global yields, a Purdue and Kansas State University study ... 150 studies from the U.S. and other regions showed ... which corn plants took up key nutrients at specific ... 5-to-1 and nitrogen and potassium at a ratio of ...
(Date:9/16/2014)... Who:, The Pulmonary Hypertension Association (PHA), ... Children’s Hospital Colorado are hosting Colorado PH in the ... association that works to find ways to prevent and cure ... affects the functioning of the heart and can lead to ... years. , What:, Colorado PH in the Park 2014 ...
Breaking Medicine News(10 mins):Health News:Dr. Michael Allon Receives Esteemed Recognition 2Health News:Do wearable lifestyle activity monitors really work? 2Health News:Do wearable lifestyle activity monitors really work? 3Health News:Results of DKCRUSH-VI trial reported at TCT 2014 2Health News:Boosting global corn yields depends on improving nutrient balance 2Health News:Boosting global corn yields depends on improving nutrient balance 3Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2
... decided to launch a ban on sale of Colas and junk ... and junk food may be out of school canteens across the ... are bad for children’s health. Hence, we want to ban the ... with Union Human Resource Development Ministry on the legal aspects of ...
... cancer is available in Singapore for those between the ... ,The Health Sciences Authority (HSA) gave its approval ... similar vaccine, Cervarix, from competitor GlaxoSmithKline, is awaiting approval ... health breakthrough, said Tay Eng Hseon, a doctor at ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... donated $30 million to University Hospitals (UH), a major ... turned his graduate thesis into a global automotive business ... himself, his wife Usha and their family, in support ... 2010. ,In recognition of the Ahuja family's ...
... treatment to remove lead from the body -- can significantly ... a// Cornell study of young rats finds. ,However, ... of autistic children, the researchers say that when rats with ... chemical, they showed declines in their learning and behavior that ...
... on women in their 70's to observe the relationship between ... followed nearly 12,000 women in// their 70’s over a 6 ... for 3-6 days/week, depending on alcoholic content) may lead to ... ,This study was published in Journal of the American ...
Cached Medicine News:Health News:Indian American Donates $30 Mn to Healthcare System 2Health News:Pros and Cons of Therapy for Lead Exposure 2
... The 50 psi MaxiCompressor, the ... to run 24 hours a ... It features a tamper-proof locking ... unintentional increases or decreases in ...
... popular and competitively priced SportNeb features ... Design enhancements include a neb kit ... black carry bag. The color SportNeb ... SportNeb also offers private labeling opportunities ...
... Treatment Compressor (230V). Same performance specifications as ... wide selection of adult and pediatric mask/nebulizer ... in a variety of international voltages and ... important part of managingthe disease state of ...
The 16 liter Laparoscopy Insufflator combines high safety and precise pressure control with simple operation....
Medicine Products: